Início
Mercados
Gráficos e ideias
Algo
Notícias
Market
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Heatmap
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
Português
English
Русский
中文
Español
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AGEN
#3725
Agenus Inc.
4.7
2
USD
+13.73%
Setor:
Cuidados de saúde
Base:
USD
Moeda do lucro:
USD
Faixa diária
Faixa anual
Mudança diária
+13.73%
Mudança mensal
+51.28%
Mudança em 6 meses
+18.30%
Mudança anual
+159.34%
Fechamento anterior
4.1
5
Abrir
4.7
2
Bid
Ask
Mínimo
4.7
2
High
4.7
2
Volume
112
Mercados
Ações
Cuidados de saúde
AGEN
Abrir gráfico completo
Financials
Visão geral
Relatórios
Estatísticas
Trimestral
Ano
Valor
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
10.23 M
12.86 M
16.63 M
20.95 M
25.31 M
38.4 M
—
Valuation ratios
Enterprise value
598.1 M
607.13 M
703.59 M
348.92 M
136.34 M
121.96 M
636.67 M
Price to earnings ratio
—
—
-3.08
-1.16
-0.26
—
—
Price to sales ratio
—
—
0.01
0
0.57
0.82
3.16
Price to cash flow ratio
—
—
-0
-0
-0.37
-1.21
-3.34
Price to book ratio
—
—
-0.01
-0
-0.18
-0.34
-0.53
Enterprise value to EBITDA ratio
20.03
2.48
-3.68
-1.74
-0.33
-2.67
—
Profitability ratios
Return on assets %
-0.85
-0.06
-0.56
-0.82
-1.03
-0.01
-0.07
Return on equity %
0.86
-0.6
4.2
1.73
0.76
0.01
-0.02
Return on invested capital %
-283.64
51.12
-271.58
-193.14
-146.85
-26.66
—
Gross margin %
97.34
98.83
89.22
98.01
99.53
99.11
396.36
Operating margin %
-132.96
8.71
-183.04
-102.07
-116.44
-17.66
-93.29
EBITDA margin %
30.76
75.07
-173.63
-99.85
-144.91
-36.29
—
Net margin %
-207.43
-9.72
-235.31
-164.69
-224.5
-2.7
-46.04
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
0.88
2.12
1.13
0.44
0.21
0.41
1.05
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.48
0.87
0.22
0.43
0.38
0.5
0.54
Solvency ratios
Debt to assets ratio
0.26
0.12
0.19
0.25
0.39
0.05
1.04
Debt to equity ratio
-0.27
1.67
-1.27
-0.49
-0.27
-0.04
-0.63
Long term debt to total assets ratio
0.09
0.03
0.03
0.04
0.13
0
0.39
Long term debt to total equity ratio
-0.09
0.37
-0.21
-0.08
-0.09
0
-0.25
Per share metrics
Operating cash flow per share
—
—
-12.45 K
-12.53 K
-7.37
-2.6
-2.77
EBIT per share
—
—
-12.57 K
-9 627.85
-7.89
-1.89
0.35
EBITDA per share
—
—
-12.08 K
-8 722.54
-6.98
-1.39
—
Total debt per share
—
—
5 526.53
4 351.41
4.07
0.37
7.68
Cash per share
—
—
13.73 K
4 252.72
1.88
0.1
1.3
Net current asset value per share
—
—
15.13 K
6 282.17
2.12
4.49
9.98
Tangible book value per share
—
—
-6 599.84
-10.59 K
-16.48
-10.03
-47.87
Working capital per share
—
—
1 715.75
-8 018.18
-8.19
-6.39
-26.49
Book value per share
—
—
-4 349.92
-8 959.82
-15.2
-9.12
-44.04
Notícias
ALLO Rises on Strong MRD Clearance With Cema-Cel in ALPHA3 Study
Agenus (AGEN) is a Great Momentum Stock: Should You Buy?
Agenus inicia ensaio de fase 3 para tratamento de câncer colorretal
Agenus Inc. (AGEN) Shareholder/Analyst Call Transcript
Agenus anuncia arquivamento de ação coletiva de valores mobiliários em Massachusetts
B.Riley reafirma preço-alvo de US$ 8 para Agenus com crescimento de receita
Agenus (AGEN) Q4 Earnings and Revenues Surpass Estimates
Agenus registra US$ 4,2 milhões em receita de acesso antecipado para terapia contra câncer
Agenus reports $4.2M in early access revenue for cancer therapy
CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates
IBD Stock Of The Day: Ligand Pharma, Biotech's Royalty Arm, Breaks Out
Agenus recebe pagamento de US$ 20 milhões de colaboração com Zydus